Data & Analytics

Advera Health Analytics’ solutions are powered by proprietary, advanced analytical tools developed to make evidence-based data not only accessible, but actionable and predicable. Built off of the data foundation provided by RxFilter®, the RxSuite is the new market standard for interpreting complex clinical and real world data. Innovative methodology, scientific data -- powerful results.

Clinical Trial Data

The Advera Health clinical trials module aggregates and optimizes results into annotated data, reconstructs them into pooled meta-analysis, and links them to post-approval updates. The result is a whole new way to look at clinical efficacy and safety data.

FAERS Data

Advera Health maintains the industry gold standard for cleaned, de-duplicated, and dynamically linked FAERS data that ensures harmonized processes and reliable data analysis. Our highly trained analyst staff enhances the automated processes by manually reviewing the machine-matching and ensures 100% accuracy. Our methodologies and results for these processes have been peer reviewed and published.

RxCost®

RxCost is the first standardized methodology to determine direct costs of adverse drug events, enabling decisions to be made based on total cost of care.

RxSignal®

RxSignal® provides an early warning system for our clients about pending FDA action to help them better identify, manage and track potential safety signals. RxSignal® builds upon traditional disproportionality analysis by adding in proprietary insights and weighting of different adverse event categories. RxSignal® has been proven to accurately predict emerging adverse event risks up to 5 years ahead of time. Our methodologies and results have been peer reviewed.

RxScore®

Similar to a FICO credit score, RxScore is the first drug safety scoring system that quickly summarizes comprehensive post-approval drug safety issues.